Evidence map›Paper›PMID 40299965›Full record

ArticleAngewandte Chemie (International ed. in English)2025

Xanthopinacol Boronate: A Robust, Photochemically Assembled and Cleavable Boronic Ester for Orthogonal Chemistry.

David M Heard, Martin C Lessard, Dennis G Hall

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

David M Heard *Department of Chemistry, 4-010 Centennial Centre for Interdisciplinary Science, University of Alberta, 11335 Saskatchewan Dr NW, Edmonton, AB, T6G2G2, Canada.
Martin C Lessard *Department of Chemistry, 4-010 Centennial Centre for Interdisciplinary Science, University of Alberta, 11335 Saskatchewan Dr NW, Edmonton, AB, T6G2G2, Canada.
Dennis G HallDepartment of Chemistry, 4-010 Centennial Centre for Interdisciplinary Science, University of Alberta, 11335 Saskatchewan Dr NW, Edmonton, AB, T6G2G2, Canada.

Funding

Natural Sciences and Engineering Research Council
6 · The paper itself

Abstract

Organoboronic acids impact numerous fields of application from organic synthesis to drug discovery and materials science. However, their highly polar nature makes them challenging to handle, purify, and characterize. Boronic esters help overcome these issues, and pinacol esters (Bpin) have become the dominant boronic acid surrogate in organic synthesis. Despite its popularity, Bpin is not without drawbacks. Its formation from pinacol is intrinsically reversible in the presence of water or alcohols, which may cause premature release leading to losses during reactions and purification. This reversibility complicates the hydrolytic regeneration of free boronic acids, which often requires additional steps to destroy the pinacol by-product. Although other boronyl protecting groups exist, their removal requires harsh pH conditions. To address these issues, we developed xanthopinacol boronates (Bxpin), a robust protecting group for boronic acids with excellent orthogonality in various chemical reactions and mild irreversible removal under catalyzed photoredox conditions. Xpin boronates can be obtained directly by irradiation of a mixture of free boronic acid and xanthone with UV light, causing an in situ dimerization of xanthone to the required xanthopinacol. The unique attributes of xpin boronates were further studied by UV-vis spectrophotometry, X-ray crystallography, cyclic voltammetry, and various stability tests.

Indexed as

Boronic acidBoronic esterOrthogonal reactionsOxidative cleavagePhotochemistry

Identifiers

PMID40299965
PMCPMC12232895

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.